Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: Correlation of protein levels with drug response and messenger RNA levels

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1798-1804

  Young, L C ^a   Campling, B G ^a   Cole, S P C ^a   Deeley, R G ^a   Gerlach, J H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; POLYCLONAL ANTIBODY; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING;

AMIDOHYDROLASES; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL MEMBRANE; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FUNGAL PROTEINS; HUMANS; IMMUNOGLOBULIN G; LUNG NEOPLASMS; MITOCHONDRIAL PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PHENOTYPE; POLYMERASE CHAIN REACTION; PYRUVATE DEHYDROGENASE COMPLEX; RIBOSOMAL PROTEINS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0034895918     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. An inventory of the human ABC proteins
2. MDR1 gene expression in lung cancer
3. Expression of the MRP and MDRI multidrug resistance genes in small cell lung cancer
4. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response
5. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
6. Expression of the multidrug resistance associated-protein (MRP) gene in non-small-cell lung cancer
7. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
8. Multidrug resistance protein in recurrent breast cancer
9. Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer
10. Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein
11. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma
12. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma
13. Multidrug-resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
14. Expression of multidrug resistance-associated protein in endometrial carcinomas: Correlation with clinicopathology and prognosis
15. MRP expression in acute myeloid leukemia
16. The multidrug resistance protein family
17. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1) in human cancer cell lines
18. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
19. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
20. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
21. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRPI transporting protein
22. Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes
23. Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes
24. MRP3, an organic anion transporter able to transport anticancer drugs
25. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
26. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)
27. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
28. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter
29. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
30. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents
31. Establishment and characterization of a panel of human lung cancer cell lines
32. Chemosensitivity testing of small cell lung cancer using the MTT assay
33. Dose response analysis of chemosensitivity testing of small cell lung cancer using the MTT assay
34. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies
35. Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1
36. Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
37. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
38. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
39. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
40. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells
41. Pharmacological characterization of multidrug-resistant MRP-transfected human tumor cells
42. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
43. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells
44. Immunohistochemical detection of multidrug-resistance protein (MRP) in human lung cancer and normal lung
45. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small cell lung cancer cells
46. Multidrug resistance-associated protein expression in clinical gastric carcinoma
47. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells
48. Expression of γ-glutamylcysteine synthetase (γ-GCS) and multidrug-resistance associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs
49. Increased expression of an ATP-binding cassette superfamily transporter, multidrugresistance protein 2, in human colorectal carcinomas